Vascular endothelial stem cells (VESCs) based therapy is a promising approach for vascular regeneration.
CHRNB2, a novel target for gastric cancer, potentially other tumors
By using a novel, non-radioactive, chelate-forming compound.
(Update): Anti-CKAP4 Monoclonal Antibody Obtained
A novel technology loosens tight junction of BBB and supports drug transportation into brain.
Useful for gene therapy by minimizing non-homologous end joining (NHEJ) derived Insertions or deletions (Indels)
Selective inhibition of Periostin variant (PN1) by monoclonal antibody
Excellent Vaccine Development/Research Platform
Achieved targeted large size gene knock-in animal production.
Cell Surface Antigen CD48 as A Novel Molecular Target for Antibody Therapy in Multiple Myeloma